Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Brotzu lotion update

      in Update  89 upvotes 8 years ago
      A new hair loss lotion by Dr. Brotzu, expected to regrow up to 5 years of lost hair, is set to be released by Fidia Farmaceutici. It claims to work like minoxidil and finasteride without side effects, but skepticism exists due to its classification as a cosmetic product.

      community Suffering from intense sides from dutasteride

       17 upvotes 8 years ago
      A person experienced severe sexual side effects, including loss of libido and erectile dysfunction, after using finasteride and dutasteride for hair loss. They stopped the medications and sought advice, but recovery was slow and uncertain.

      community Went to the derm..

       16 upvotes 10 years ago
      Finasteride is recommended for hair loss treatment, with potential side effects like erectile issues in 1 in 33 users, which typically resolve after stopping the drug. Users report mixed experiences, with some experiencing initial side effects like brain fog and others seeing no issues, and the drug is generally considered effective for maintaining or regrowing hair.

      community Best available SARD right now?

      in Treatment  3 upvotes 1 month ago
      The user is considering RU58841 and has been using dutasteride since age 17. They are seeking affordable SARD options, mentioning ASC-J9, GT20029, and AH001.

      community The Hormonal Profile of MPB/AGA

      in Research/Science  9 upvotes 5 years ago
      Men with early male pattern baldness (MPB) may have hormonal abnormalities similar to those in women with PCOS. Specific treatments mentioned include Minoxidil, Finasteride, and RU58841.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  133 upvotes 2 years ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.